Teva Pharmaceutical Industries RX
FDA Approved Drugs
Teva Pharmaceutical Industries RX
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 338
- Latest Approval Date Jul 28, 2026
- Data Source FDA
- First Approval Date Jan 01, 1982
Company Overview
Social Profiles
Company Snapshot
Teva Pharmaceutical Industries RX
5 Basel St., Petach Tikva Israel, 49131
Israel
www.tevapharm.com/ View on MapFDA Approved Drug Records ( 338 records )
Drug Name
ACITRETIN
Product Number
1
Dosage Form
-
Strength
17.5MG
Approval Date
2013-04-04
Active Ingredient
ACITRETIN
Application Number
202897
Product Number
1
Dosage Form
-
Strength
17.5MG
Approval Date
2013-04-04
Regulatory Status
RX
Drug Name
ACITRETIN
Product Number
2
Dosage Form
-
Strength
22.5MG
Approval Date
2013-04-04
Active Ingredient
ACITRETIN
Application Number
202897
Product Number
2
Dosage Form
-
Strength
22.5MG
Approval Date
2013-04-04
Regulatory Status
RX
Drug Name
ACTIGALL
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
1987-12-31
Active Ingredient
URSODIOL
Application Number
19594
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
1987-12-31
Regulatory Status
RX
Drug Name
AIRDUO RESPICLICK
Product Number
1
Dosage Form
-
Strength
0.055MG/INH;EQ 0.014MG BASE/INH
Approval Date
2017-01-27
Active Ingredient
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Application Number
208799
Product Number
1
Dosage Form
-
Strength
0.055MG/INH;EQ 0.014MG BASE/INH
Approval Date
2017-01-27
Regulatory Status
RX
Drug Name
AIRDUO RESPICLICK
Product Number
2
Dosage Form
-
Strength
0.113MG/INH;EQ 0.014MG BASE/INH
Approval Date
2017-01-27
Active Ingredient
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Application Number
208799
Product Number
2
Dosage Form
-
Strength
0.113MG/INH;EQ 0.014MG BASE/INH
Approval Date
2017-01-27
Regulatory Status
RX
Drug Name
AIRDUO RESPICLICK
Product Number
3
Dosage Form
-
Strength
0.232MG/INH;EQ 0.014MG BASE/INH
Approval Date
2017-01-27
Active Ingredient
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Application Number
208799
Product Number
3
Dosage Form
-
Strength
0.232MG/INH;EQ 0.014MG BASE/INH
Approval Date
2017-01-27
Regulatory Status
RX
Drug Name
ALMOTRIPTAN MALATE
Product Number
1
Dosage Form
-
Strength
EQ 6.25MG BASE
Approval Date
2015-07-07
Active Ingredient
ALMOTRIPTAN MALATE
Application Number
78027
Product Number
1
Dosage Form
-
Strength
EQ 6.25MG BASE
Approval Date
2015-07-07
Regulatory Status
RX
Drug Name
ALMOTRIPTAN MALATE
Product Number
2
Dosage Form
-
Strength
EQ 12.5MG BASE
Approval Date
2015-07-07
Active Ingredient
ALMOTRIPTAN MALATE
Application Number
78027
Product Number
2
Dosage Form
-
Strength
EQ 12.5MG BASE
Approval Date
2015-07-07
Regulatory Status
RX
Drug Name
ALYQ
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2019-02-05
Active Ingredient
TADALAFIL
Application Number
209942
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2019-02-05
Regulatory Status
RX
Drug Name
AMIODARONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1998-11-30
Active Ingredient
AMIODARONE HYDROCHLORIDE
Application Number
74739
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1998-11-30
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
1982-01-01
Active Ingredient
AMOXICILLIN
Application Number
61926
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
3
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Active Ingredient
AMOXICILLIN
Application Number
61926
Product Number
3
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
2
Dosage Form
-
Strength
250MG/5ML
Approval Date
1982-01-01
Active Ingredient
AMOXICILLIN
Application Number
61931
Product Number
2
Dosage Form
-
Strength
250MG/5ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
1992-12-22
Active Ingredient
AMOXICILLIN
Application Number
64013
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
1992-12-22
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
2
Dosage Form
-
Strength
125MG
Approval Date
1995-09-11
Active Ingredient
AMOXICILLIN
Application Number
64013
Product Number
2
Dosage Form
-
Strength
125MG
Approval Date
1995-09-11
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2000-09-18
Active Ingredient
AMOXICILLIN
Application Number
65056
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2000-09-18
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
2
Dosage Form
-
Strength
875MG
Approval Date
2000-09-18
Active Ingredient
AMOXICILLIN
Application Number
65056
Product Number
2
Dosage Form
-
Strength
875MG
Approval Date
2000-09-18
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
1
Dosage Form
-
Strength
200MG/5ML
Approval Date
2002-12-04
Active Ingredient
AMOXICILLIN
Application Number
65119
Product Number
1
Dosage Form
-
Strength
200MG/5ML
Approval Date
2002-12-04
Regulatory Status
RX
Drug Name
AMOXICILLIN
Product Number
2
Dosage Form
-
Strength
400MG/5ML
Approval Date
2002-12-04
Active Ingredient
AMOXICILLIN
Application Number
65119
Product Number
2
Dosage Form
-
Strength
400MG/5ML
Approval Date
2002-12-04
Regulatory Status
RX
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
1
Dosage Form
-
Strength
200MG/5ML;EQ 28.5MG BASE/5ML
Approval Date
2004-05-25
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
65089
Product Number
1
Dosage Form
-
Strength
200MG/5ML;EQ 28.5MG BASE/5ML
Approval Date
2004-05-25
Regulatory Status
RX
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
2
Dosage Form
-
Strength
400MG/5ML;EQ 57MG BASE/5ML
Approval Date
2004-05-25
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
65089
Product Number
2
Dosage Form
-
Strength
400MG/5ML;EQ 57MG BASE/5ML
Approval Date
2004-05-25
Regulatory Status
RX
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
1
Dosage Form
-
Strength
875MG;EQ 125MG BASE
Approval Date
2002-10-29
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
65096
Product Number
1
Dosage Form
-
Strength
875MG;EQ 125MG BASE
Approval Date
2002-10-29
Regulatory Status
RX
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
1
Dosage Form
-
Strength
500MG;EQ 125MG BASE
Approval Date
2002-10-30
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
65101
Product Number
1
Dosage Form
-
Strength
500MG;EQ 125MG BASE
Approval Date
2002-10-30
Regulatory Status
RX
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
1
Dosage Form
-
Strength
600MG/5ML;EQ 42.9MG BASE/5ML
Approval Date
2004-03-12
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
65162
Product Number
1
Dosage Form
-
Strength
600MG/5ML;EQ 42.9MG BASE/5ML
Approval Date
2004-03-12
Regulatory Status
RX
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
1
Dosage Form
-
Strength
200MG;EQ 28.5MG BASE
Approval Date
2005-02-09
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
65205
Product Number
1
Dosage Form
-
Strength
200MG;EQ 28.5MG BASE
Approval Date
2005-02-09
Regulatory Status
RX
Drug Name
AMOXICILLIN AND CLAVULANATE POTASSIUM
Product Number
2
Dosage Form
-
Strength
400MG;EQ 57MG BASE
Approval Date
2005-02-09
Active Ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Application Number
65205
Product Number
2
Dosage Form
-
Strength
400MG;EQ 57MG BASE
Approval Date
2005-02-09
Regulatory Status
RX
Drug Name
AMOXICILLIN PEDIATRIC
Product Number
3
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-12-01
Active Ingredient
AMOXICILLIN
Application Number
61931
Product Number
3
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-12-01
Regulatory Status
RX
Drug Name
ANASTROZOLE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2010-06-28
Active Ingredient
ANASTROZOLE
Application Number
78058
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2010-06-28
Regulatory Status
RX
Drug Name
ATAZANAVIR SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2014-04-22
Active Ingredient
ATAZANAVIR SULFATE
Application Number
91673
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2014-04-22
Regulatory Status
RX
Drug Name
ATAZANAVIR SULFATE
Product Number
2
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2014-04-22
Active Ingredient
ATAZANAVIR SULFATE
Application Number
91673
Product Number
2
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2014-04-22
Regulatory Status
RX
Drug Name
ATAZANAVIR SULFATE
Product Number
3
Dosage Form
-
Strength
EQ 200MG BASE
Approval Date
2014-04-22
Active Ingredient
ATAZANAVIR SULFATE
Application Number
91673
Product Number
3
Dosage Form
-
Strength
EQ 200MG BASE
Approval Date
2014-04-22
Regulatory Status
RX
Drug Name
ATAZANAVIR SULFATE
Product Number
4
Dosage Form
-
Strength
EQ 300MG BASE
Approval Date
2014-04-22
Active Ingredient
ATAZANAVIR SULFATE
Application Number
91673
Product Number
4
Dosage Form
-
Strength
EQ 300MG BASE
Approval Date
2014-04-22
Regulatory Status
RX
Drug Name
ATOMOXETINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2017-05-30
Active Ingredient
ATOMOXETINE HYDROCHLORIDE
Application Number
79022
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2017-05-30
Regulatory Status
RX
Drug Name
ATOMOXETINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 18MG BASE
Approval Date
2017-05-30
Active Ingredient
ATOMOXETINE HYDROCHLORIDE
Application Number
79022
Product Number
2
Dosage Form
-
Strength
EQ 18MG BASE
Approval Date
2017-05-30
Regulatory Status
RX
Drug Name
ATOMOXETINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2017-05-30
Active Ingredient
ATOMOXETINE HYDROCHLORIDE
Application Number
79022
Product Number
3
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2017-05-30
Regulatory Status
RX
Drug Name
ATOMOXETINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2017-05-30
Active Ingredient
ATOMOXETINE HYDROCHLORIDE
Application Number
79022
Product Number
4
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2017-05-30
Regulatory Status
RX
Drug Name
ATOMOXETINE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
EQ 60MG BASE
Approval Date
2017-05-30
Active Ingredient
ATOMOXETINE HYDROCHLORIDE
Application Number
79022
Product Number
5
Dosage Form
-
Strength
EQ 60MG BASE
Approval Date
2017-05-30
Regulatory Status
RX
Drug Name
ATOMOXETINE HYDROCHLORIDE
Product Number
6
Dosage Form
-
Strength
EQ 80MG BASE
Approval Date
2017-05-30
Active Ingredient
ATOMOXETINE HYDROCHLORIDE
Application Number
79022
Product Number
6
Dosage Form
-
Strength
EQ 80MG BASE
Approval Date
2017-05-30
Regulatory Status
RX
Drug Name
ATOMOXETINE HYDROCHLORIDE
Product Number
7
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2017-05-30
Active Ingredient
ATOMOXETINE HYDROCHLORIDE
Application Number
79022
Product Number
7
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2017-05-30
Regulatory Status
RX
Drug Name
ATORVASTATIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2017-03-27
Active Ingredient
ATORVASTATIN CALCIUM
Application Number
205300
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2017-03-27
Regulatory Status
RX
Drug Name
ATORVASTATIN CALCIUM
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2017-03-27
Active Ingredient
ATORVASTATIN CALCIUM
Application Number
205300
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2017-03-27
Regulatory Status
RX
Drug Name
ATORVASTATIN CALCIUM
Product Number
3
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2017-03-27
Active Ingredient
ATORVASTATIN CALCIUM
Application Number
205300
Product Number
3
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2017-03-27
Regulatory Status
RX
Drug Name
ATORVASTATIN CALCIUM
Product Number
4
Dosage Form
-
Strength
EQ 80MG BASE
Approval Date
2017-03-27
Active Ingredient
ATORVASTATIN CALCIUM
Application Number
205300
Product Number
4
Dosage Form
-
Strength
EQ 80MG BASE
Approval Date
2017-03-27
Regulatory Status
RX
Drug Name
AUSTEDO
Product Number
1
Dosage Form
-
Strength
6MG
Approval Date
2017-04-03
Active Ingredient
DEUTETRABENAZINE
Application Number
208082
Product Number
1
Dosage Form
-
Strength
6MG
Approval Date
2017-04-03
Regulatory Status
RX
Drug Name
AUSTEDO
Product Number
2
Dosage Form
-
Strength
9MG
Approval Date
2017-04-03
Active Ingredient
DEUTETRABENAZINE
Application Number
208082
Product Number
2
Dosage Form
-
Strength
9MG
Approval Date
2017-04-03
Regulatory Status
RX
Drug Name
AUSTEDO
Product Number
3
Dosage Form
-
Strength
12MG
Approval Date
2017-04-03
Active Ingredient
DEUTETRABENAZINE
Application Number
208082
Product Number
3
Dosage Form
-
Strength
12MG
Approval Date
2017-04-03
Regulatory Status
RX
Drug Name
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
Product Number
1
Dosage Form
-
Strength
0.137MG/SPRAY;0.05MG/SPRAY
Approval Date
2025-04-08
Active Ingredient
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
Application Number
208436
Product Number
1
Dosage Form
-
Strength
0.137MG/SPRAY;0.05MG/SPRAY
Approval Date
2025-04-08
Regulatory Status
RX
Drug Name
BEXAROTENE
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
2021-01-14
Active Ingredient
BEXAROTENE
Application Number
209931
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
2021-01-14
Regulatory Status
RX
Drug Name
BUDESONIDE
Product Number
1
Dosage Form
-
Strength
0.25MG/2ML
Approval Date
2008-11-18
Active Ingredient
BUDESONIDE
Application Number
77519
Product Number
1
Dosage Form
-
Strength
0.25MG/2ML
Approval Date
2008-11-18
Regulatory Status
RX
Drug Name
BUDESONIDE
Product Number
2
Dosage Form
-
Strength
0.5MG/2ML
Approval Date
2008-11-18
Active Ingredient
BUDESONIDE
Application Number
77519
Product Number
2
Dosage Form
-
Strength
0.5MG/2ML
Approval Date
2008-11-18
Regulatory Status
RX
Drug Name
BUDESONIDE
Product Number
1
Dosage Form
-
Strength
1MG/2ML
Approval Date
2016-03-08
Active Ingredient
BUDESONIDE
Application Number
204548
Product Number
1
Dosage Form
-
Strength
1MG/2ML
Approval Date
2016-03-08
Regulatory Status
RX
Drug Name
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE
Product Number
1
Dosage Form
-
Strength
0.08MG/INH;0.0045MG/INH
Approval Date
2026-04-23
Active Ingredient
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
Application Number
212212
Product Number
1
Dosage Form
-
Strength
0.08MG/INH;0.0045MG/INH
Approval Date
2026-04-23
Regulatory Status
RX
Drug Name
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE
Product Number
2
Dosage Form
-
Strength
0.16MG/INH;0.0045MG/INH
Approval Date
2026-04-23
Active Ingredient
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
Application Number
212212
Product Number
2
Dosage Form
-
Strength
0.16MG/INH;0.0045MG/INH
Approval Date
2026-04-23
Regulatory Status
RX
Drug Name
CAPECITABINE
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2013-09-16
Active Ingredient
CAPECITABINE
Application Number
91649
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2013-09-16
Regulatory Status
RX
Drug Name
CAPECITABINE
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2013-09-16
Active Ingredient
CAPECITABINE
Application Number
91649
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2013-09-16
Regulatory Status
RX
Drug Name
CARBAMAZEPINE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2012-09-20
Active Ingredient
CARBAMAZEPINE
Application Number
78592
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2012-09-20
Regulatory Status
RX
Drug Name
CARBAMAZEPINE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2012-09-20
Active Ingredient
CARBAMAZEPINE
Application Number
78592
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2012-09-20
Regulatory Status
RX
Drug Name
CARBAMAZEPINE
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
2012-09-20
Active Ingredient
CARBAMAZEPINE
Application Number
78592
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
2012-09-20
Regulatory Status
RX
Drug Name
CEFADROXIL
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE
Approval Date
1987-04-08
Active Ingredient
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Application Number
62774
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE
Approval Date
1987-04-08
Regulatory Status
RX
Drug Name
CEFADROXIL
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2006-01-20
Active Ingredient
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Application Number
65282
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2006-01-20
Regulatory Status
RX
Drug Name
CEFDINIR
Product Number
1
Dosage Form
-
Strength
125MG/5ML
Approval Date
2007-05-04
Active Ingredient
CEFDINIR
Application Number
65332
Product Number
1
Dosage Form
-
Strength
125MG/5ML
Approval Date
2007-05-04
Regulatory Status
RX
Drug Name
CEFDINIR
Product Number
2
Dosage Form
-
Strength
250MG/5ML
Approval Date
2007-05-04
Active Ingredient
CEFDINIR
Application Number
65332
Product Number
2
Dosage Form
-
Strength
250MG/5ML
Approval Date
2007-05-04
Regulatory Status
RX
Drug Name
CEFDINIR
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2007-05-09
Active Ingredient
CEFDINIR
Application Number
65368
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2007-05-09
Regulatory Status
RX
Drug Name
CHLORPROMAZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2021-10-25
Active Ingredient
CHLORPROMAZINE HYDROCHLORIDE
Application Number
215659
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2021-10-25
Regulatory Status
RX
Drug Name
CHLORPROMAZINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2021-10-25
Active Ingredient
CHLORPROMAZINE HYDROCHLORIDE
Application Number
215659
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2021-10-25
Regulatory Status
RX
Drug Name
CHLORPROMAZINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
2021-10-25
Active Ingredient
CHLORPROMAZINE HYDROCHLORIDE
Application Number
215659
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
2021-10-25
Regulatory Status
RX
Drug Name
CHLORPROMAZINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
2021-10-25
Active Ingredient
CHLORPROMAZINE HYDROCHLORIDE
Application Number
215659
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
2021-10-25
Regulatory Status
RX
Drug Name
CHLORPROMAZINE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
200MG
Approval Date
2021-10-25
Active Ingredient
CHLORPROMAZINE HYDROCHLORIDE
Application Number
215659
Product Number
5
Dosage Form
-
Strength
200MG
Approval Date
2021-10-25
Regulatory Status
RX
Drug Name
CLARAVIS
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2003-04-11
Active Ingredient
ISOTRETINOIN
Application Number
76135
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2003-04-11
Regulatory Status
RX
Drug Name
CLARAVIS
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2003-04-11
Active Ingredient
ISOTRETINOIN
Application Number
76135
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2003-04-11
Regulatory Status
RX
Drug Name
CLARAVIS
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2006-05-11
Active Ingredient
ISOTRETINOIN
Application Number
76135
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2006-05-11
Regulatory Status
RX
Drug Name
CLARAVIS
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2003-04-11
Active Ingredient
ISOTRETINOIN
Application Number
76356
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2003-04-11
Regulatory Status
RX
Drug Name
COPAXONE
Product Number
2
Dosage Form
-
Strength
20MG/ML
Approval Date
2002-02-12
Active Ingredient
GLATIRAMER ACETATE
Application Number
20622
Product Number
2
Dosage Form
-
Strength
20MG/ML
Approval Date
2002-02-12
Regulatory Status
RX
Drug Name
COPAXONE
Product Number
3
Dosage Form
-
Strength
40MG/ML
Approval Date
2014-01-28
Active Ingredient
GLATIRAMER ACETATE
Application Number
20622
Product Number
3
Dosage Form
-
Strength
40MG/ML
Approval Date
2014-01-28
Regulatory Status
RX
Drug Name
CROMOLYN SODIUM
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2000-01-18
Active Ingredient
CROMOLYN SODIUM
Application Number
75271
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2000-01-18
Regulatory Status
RX
Drug Name
CYCLOSPORINE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2023-12-14
Active Ingredient
CYCLOSPORINE
Application Number
203880
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2023-12-14
Regulatory Status
RX
Drug Name
DAPAGLIFLOZIN
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2026-04-06
Active Ingredient
DAPAGLIFLOZIN
Application Number
211541
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2026-04-06
Regulatory Status
RX
Drug Name
DAPAGLIFLOZIN
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2026-04-06
Active Ingredient
DAPAGLIFLOZIN
Application Number
211541
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2026-04-06
Regulatory Status
RX
Drug Name
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
2.5MG;1GM
Approval Date
2026-04-06
Active Ingredient
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Application Number
211583
Product Number
1
Dosage Form
-
Strength
2.5MG;1GM
Approval Date
2026-04-06
Regulatory Status
RX
Drug Name
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
5MG;500MG
Approval Date
2026-04-06
Active Ingredient
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Application Number
211583
Product Number
2
Dosage Form
-
Strength
5MG;500MG
Approval Date
2026-04-06
Regulatory Status
RX
Drug Name
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
5MG;1GM
Approval Date
2026-04-06
Active Ingredient
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Application Number
211583
Product Number
3
Dosage Form
-
Strength
5MG;1GM
Approval Date
2026-04-06
Regulatory Status
RX
Drug Name
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
10MG;500MG
Approval Date
2026-04-06
Active Ingredient
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Application Number
211583
Product Number
4
Dosage Form
-
Strength
10MG;500MG
Approval Date
2026-04-06
Regulatory Status
RX
Drug Name
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
10MG;1GM
Approval Date
2026-04-06
Active Ingredient
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Application Number
211583
Product Number
5
Dosage Form
-
Strength
10MG;1GM
Approval Date
2026-04-06
Regulatory Status
RX
Drug Name
DAPTOMYCIN
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2016-03-25
Active Ingredient
DAPTOMYCIN
Application Number
91039
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2016-03-25
Regulatory Status
RX
Drug Name
DASATINIB
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2025-08-27
Active Ingredient
DASATINIB
Application Number
211094
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2025-08-27
Regulatory Status
RX
Drug Name
DASATINIB
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2025-08-27
Active Ingredient
DASATINIB
Application Number
211094
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2025-08-27
Regulatory Status
RX
Drug Name
DASATINIB
Product Number
3
Dosage Form
-
Strength
70MG
Approval Date
2025-08-27
Active Ingredient
DASATINIB
Application Number
211094
Product Number
3
Dosage Form
-
Strength
70MG
Approval Date
2025-08-27
Regulatory Status
RX
Drug Name
DASATINIB
Product Number
4
Dosage Form
-
Strength
80MG
Approval Date
2025-08-27
Active Ingredient
DASATINIB
Application Number
211094
Product Number
4
Dosage Form
-
Strength
80MG
Approval Date
2025-08-27
Regulatory Status
RX
Drug Name
DASATINIB
Product Number
5
Dosage Form
-
Strength
100MG
Approval Date
2025-08-27
Active Ingredient
DASATINIB
Application Number
211094
Product Number
5
Dosage Form
-
Strength
100MG
Approval Date
2025-08-27
Regulatory Status
RX
Drug Name
DASATINIB
Product Number
6
Dosage Form
-
Strength
140MG
Approval Date
2025-08-27
Active Ingredient
DASATINIB
Application Number
211094
Product Number
6
Dosage Form
-
Strength
140MG
Approval Date
2025-08-27
Regulatory Status
RX
Drug Name
DEFERASIROX
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2022-09-23
Active Ingredient
DEFERASIROX
Application Number
207124
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2022-09-23
Regulatory Status
RX
Drug Name
DEFERASIROX
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2022-09-23
Active Ingredient
DEFERASIROX
Application Number
207124
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2022-09-23
Regulatory Status
RX
Drug Name
DEFERASIROX
Product Number
3
Dosage Form
-
Strength
500MG
Approval Date
2022-09-23
Active Ingredient
DEFERASIROX
Application Number
207124
Product Number
3
Dosage Form
-
Strength
500MG
Approval Date
2022-09-23
Regulatory Status
RX
Drug Name
DEXMEDETOMIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML)
Approval Date
2017-11-28
Active Ingredient
DEXMEDETOMIDINE HYDROCHLORIDE
Application Number
205272
Product Number
1
Dosage Form
-
Strength
EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML)
Approval Date
2017-11-28
Regulatory Status
RX
Drug Name
DEXMETHYLPHENIDATE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2013-11-19
Active Ingredient
DEXMETHYLPHENIDATE HYDROCHLORIDE
Application Number
78908
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2013-11-19
Regulatory Status
RX
Drug Name
DEXMETHYLPHENIDATE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2013-11-19
Active Ingredient
DEXMETHYLPHENIDATE HYDROCHLORIDE
Application Number
78908
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2013-11-19
Regulatory Status
RX
Drug Name
DEXMETHYLPHENIDATE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
20MG
Approval Date
2013-11-19
Active Ingredient
DEXMETHYLPHENIDATE HYDROCHLORIDE
Application Number
78908
Product Number
3
Dosage Form
-
Strength
20MG
Approval Date
2013-11-19
Regulatory Status
RX
Drug Name
DEXMETHYLPHENIDATE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
15MG
Approval Date
2014-05-19
Active Ingredient
DEXMETHYLPHENIDATE HYDROCHLORIDE
Application Number
78908
Product Number
4
Dosage Form
-
Strength
15MG
Approval Date
2014-05-19
Regulatory Status
RX
Drug Name
DEXMETHYLPHENIDATE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2017-07-05
Active Ingredient
DEXMETHYLPHENIDATE HYDROCHLORIDE
Application Number
202731
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2017-07-05
Regulatory Status
RX
Drug Name
DEXMETHYLPHENIDATE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
2013-11-19
Active Ingredient
DEXMETHYLPHENIDATE HYDROCHLORIDE
Application Number
202731
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
2013-11-19
Regulatory Status
RX
Drug Name
DEXMETHYLPHENIDATE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2014-05-19
Active Ingredient
DEXMETHYLPHENIDATE HYDROCHLORIDE
Application Number
202731
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2014-05-19
Regulatory Status
RX
Drug Name
DEXMETHYLPHENIDATE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
35MG
Approval Date
2017-07-05
Active Ingredient
DEXMETHYLPHENIDATE HYDROCHLORIDE
Application Number
202731
Product Number
4
Dosage Form
-
Strength
35MG
Approval Date
2017-07-05
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
1
Dosage Form
-
Strength
3.125MG;3.125MG;3.125MG;3.125MG
Approval Date
2022-01-31
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
210876
Product Number
1
Dosage Form
-
Strength
3.125MG;3.125MG;3.125MG;3.125MG
Approval Date
2022-01-31
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
2
Dosage Form
-
Strength
6.25MG;6.25MG;6.25MG;6.25MG
Approval Date
2022-01-31
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
210876
Product Number
2
Dosage Form
-
Strength
6.25MG;6.25MG;6.25MG;6.25MG
Approval Date
2022-01-31
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
3
Dosage Form
-
Strength
9.375MG;9.375MG;9.375MG;9.375MG
Approval Date
2022-01-31
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
210876
Product Number
3
Dosage Form
-
Strength
9.375MG;9.375MG;9.375MG;9.375MG
Approval Date
2022-01-31
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
4
Dosage Form
-
Strength
12.5MG;12.5MG;12.5MG;12.5MG
Approval Date
2022-01-31
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
210876
Product Number
4
Dosage Form
-
Strength
12.5MG;12.5MG;12.5MG;12.5MG
Approval Date
2022-01-31
Regulatory Status
RX
Drug Name
DICLOXACILLIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
1982-06-03
Active Ingredient
DICLOXACILLIN SODIUM
Application Number
62286
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
1982-06-03
Regulatory Status
RX
Drug Name
DICLOXACILLIN SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
1982-06-03
Active Ingredient
DICLOXACILLIN SODIUM
Application Number
62286
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
1982-06-03
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5%
Approval Date
2023-02-17
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
215408
Product Number
1
Dosage Form
-
Strength
5%
Approval Date
2023-02-17
Regulatory Status
RX
Drug Name
EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
600MG;200MG;300MG
Approval Date
2018-11-09
Active Ingredient
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Application Number
91215
Product Number
1
Dosage Form
-
Strength
600MG;200MG;300MG
Approval Date
2018-11-09
Regulatory Status
RX
Drug Name
EFINACONAZOLE
Product Number
1
Dosage Form
-
Strength
10%
Approval Date
2020-12-16
Active Ingredient
EFINACONAZOLE
Application Number
211827
Product Number
1
Dosage Form
-
Strength
10%
Approval Date
2020-12-16
Regulatory Status
RX
Drug Name
ELETRIPTAN HYDROBROMIDE
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2017-06-27
Active Ingredient
ELETRIPTAN HYDROBROMIDE
Application Number
202040
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2017-06-27
Regulatory Status
RX
Drug Name
ELETRIPTAN HYDROBROMIDE
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2017-06-27
Active Ingredient
ELETRIPTAN HYDROBROMIDE
Application Number
202040
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2017-06-27
Regulatory Status
RX
Drug Name
ELTROMBOPAG OLAMINE
Product Number
1
Dosage Form
-
Strength
EQ 12.5MG ACID
Approval Date
2026-07-13
Active Ingredient
ELTROMBOPAG OLAMINE
Application Number
209938
Product Number
1
Dosage Form
-
Strength
EQ 12.5MG ACID
Approval Date
2026-07-13
Regulatory Status
RX
Drug Name
ELTROMBOPAG OLAMINE
Product Number
2
Dosage Form
-
Strength
EQ 25MG ACID
Approval Date
2026-07-13
Active Ingredient
ELTROMBOPAG OLAMINE
Application Number
209938
Product Number
2
Dosage Form
-
Strength
EQ 25MG ACID
Approval Date
2026-07-13
Regulatory Status
RX
Drug Name
ELTROMBOPAG OLAMINE
Product Number
3
Dosage Form
-
Strength
EQ 75MG ACID
Approval Date
2026-07-13
Active Ingredient
ELTROMBOPAG OLAMINE
Application Number
209938
Product Number
3
Dosage Form
-
Strength
EQ 75MG ACID
Approval Date
2026-07-13
Regulatory Status
RX
Drug Name
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
200MG;300MG
Approval Date
2017-06-08
Active Ingredient
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Application Number
90894
Product Number
1
Dosage Form
-
Strength
200MG;300MG
Approval Date
2017-06-08
Regulatory Status
RX
Drug Name
EPINEPHRINE (AUTOINJECTOR)
Product Number
1
Dosage Form
-
Strength
0.3MG/DELIVERY
Approval Date
2018-08-16
Active Ingredient
EPINEPHRINE
Application Number
90589
Product Number
1
Dosage Form
-
Strength
0.3MG/DELIVERY
Approval Date
2018-08-16
Regulatory Status
RX
Drug Name
EPINEPHRINE (AUTOINJECTOR)
Product Number
2
Dosage Form
-
Strength
0.15MG/DELIVERY
Approval Date
2018-08-16
Active Ingredient
EPINEPHRINE
Application Number
90589
Product Number
2
Dosage Form
-
Strength
0.15MG/DELIVERY
Approval Date
2018-08-16
Regulatory Status
RX
Drug Name
EPTIFIBATIDE
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2015-06-12
Active Ingredient
EPTIFIBATIDE
Application Number
90854
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
2015-06-12
Regulatory Status
RX
Drug Name
ERLOTINIB HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2020-11-09
Active Ingredient
ERLOTINIB HYDROCHLORIDE
Application Number
91059
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2020-11-09
Regulatory Status
RX
Drug Name
ERLOTINIB HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2015-08-28
Active Ingredient
ERLOTINIB HYDROCHLORIDE
Application Number
91059
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2015-08-28
Regulatory Status
RX
Drug Name
ERLOTINIB HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2015-08-28
Active Ingredient
ERLOTINIB HYDROCHLORIDE
Application Number
91059
Product Number
3
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2015-08-28
Regulatory Status
RX
Drug Name
ERYTHROMYCIN
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2021-02-11
Active Ingredient
ERYTHROMYCIN
Application Number
214549
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2021-02-11
Regulatory Status
RX
Drug Name
ERYTHROMYCIN
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2021-02-11
Active Ingredient
ERYTHROMYCIN
Application Number
214549
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2021-02-11
Regulatory Status
RX
Drug Name
ESTRADIOL
Product Number
1
Dosage Form
-
Strength
10MCG
Approval Date
2017-07-21
Active Ingredient
ESTRADIOL
Application Number
206388
Product Number
1
Dosage Form
-
Strength
10MCG
Approval Date
2017-07-21
Regulatory Status
RX
Drug Name
ESTRADIOL
Product Number
1
Dosage Form
-
Strength
0.01%
Approval Date
2018-03-30
Active Ingredient
ESTRADIOL
Application Number
210488
Product Number
1
Dosage Form
-
Strength
0.01%
Approval Date
2018-03-30
Regulatory Status
RX
Drug Name
ESTRADIOL
Product Number
1
Dosage Form
-
Strength
0.004MG
Approval Date
2025-12-08
Active Ingredient
ESTRADIOL
Application Number
214137
Product Number
1
Dosage Form
-
Strength
0.004MG
Approval Date
2025-12-08
Regulatory Status
RX
Drug Name
ESTRADIOL
Product Number
2
Dosage Form
-
Strength
0.01MG
Approval Date
2025-12-08
Active Ingredient
ESTRADIOL
Application Number
214137
Product Number
2
Dosage Form
-
Strength
0.01MG
Approval Date
2025-12-08
Regulatory Status
RX
Drug Name
ETHINYL ESTRADIOL; ETONOGESTREL
Product Number
1
Dosage Form
-
Strength
0.015MG/24HR;0.12MG/24HR
Approval Date
2021-01-13
Active Ingredient
ETHINYL ESTRADIOL; ETONOGESTREL
Application Number
204305
Product Number
1
Dosage Form
-
Strength
0.015MG/24HR;0.12MG/24HR
Approval Date
2021-01-13
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2019-12-09
Active Ingredient
EVEROLIMUS
Application Number
210050
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2019-12-09
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2019-12-09
Active Ingredient
EVEROLIMUS
Application Number
210050
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2019-12-09
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2019-12-09
Active Ingredient
EVEROLIMUS
Application Number
210050
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2019-12-09
Regulatory Status
RX
Drug Name
EVEROLIMUS
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2019-12-09
Active Ingredient
EVEROLIMUS
Application Number
210050
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2019-12-09
Regulatory Status
RX
Drug Name
FAMCICLOVIR
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2007-08-24
Active Ingredient
FAMCICLOVIR
Application Number
77487
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2007-08-24
Regulatory Status
RX
Drug Name
FAMCICLOVIR
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2007-08-24
Active Ingredient
FAMCICLOVIR
Application Number
77487
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2007-08-24
Regulatory Status
RX
Drug Name
FAMCICLOVIR
Product Number
3
Dosage Form
-
Strength
500MG
Approval Date
2007-08-24
Active Ingredient
FAMCICLOVIR
Application Number
77487
Product Number
3
Dosage Form
-
Strength
500MG
Approval Date
2007-08-24
Regulatory Status
RX
Drug Name
FERRIC CITRATE
Product Number
1
Dosage Form
-
Strength
EQ 210MG IRON
Approval Date
2026-03-11
Active Ingredient
FERRIC CITRATE
Application Number
212563
Product Number
1
Dosage Form
-
Strength
EQ 210MG IRON
Approval Date
2026-03-11
Regulatory Status
RX
Drug Name
FINGOLIMOD HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.5MG BASE
Approval Date
2020-07-02
Active Ingredient
FINGOLIMOD HYDROCHLORIDE
Application Number
208008
Product Number
1
Dosage Form
-
Strength
EQ 0.5MG BASE
Approval Date
2020-07-02
Regulatory Status
RX
Drug Name
FINZALA
Product Number
1
Dosage Form
-
Strength
0.02MG;1MG
Approval Date
2020-04-07
Active Ingredient
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Application Number
210087
Product Number
1
Dosage Form
-
Strength
0.02MG;1MG
Approval Date
2020-04-07
Regulatory Status
RX
Drug Name
FLUOXETINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2002-01-29
Active Ingredient
FLUOXETINE HYDROCHLORIDE
Application Number
76001
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2002-01-29
Regulatory Status
RX
Drug Name
FLUOXETINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2002-01-29
Active Ingredient
FLUOXETINE HYDROCHLORIDE
Application Number
76001
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2002-01-29
Regulatory Status
RX
Drug Name
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
Product Number
1
Dosage Form
-
Strength
0.1MG/INH;EQ 0.05MG BASE/INH
Approval Date
2021-12-13
Active Ingredient
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Application Number
213948
Product Number
1
Dosage Form
-
Strength
0.1MG/INH;EQ 0.05MG BASE/INH
Approval Date
2021-12-13
Regulatory Status
RX
Drug Name
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
Product Number
2
Dosage Form
-
Strength
0.25MG/INH;EQ 0.05MG BASE/INH
Approval Date
2021-12-13
Active Ingredient
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Application Number
213948
Product Number
2
Dosage Form
-
Strength
0.25MG/INH;EQ 0.05MG BASE/INH
Approval Date
2021-12-13
Regulatory Status
RX
Drug Name
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
Product Number
3
Dosage Form
-
Strength
0.5MG/INH;EQ 0.05MG BASE/INH
Approval Date
2021-12-13
Active Ingredient
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Application Number
213948
Product Number
3
Dosage Form
-
Strength
0.5MG/INH;EQ 0.05MG BASE/INH
Approval Date
2021-12-13
Regulatory Status
RX
Drug Name
FLUVASTATIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2012-06-12
Active Ingredient
FLUVASTATIN SODIUM
Application Number
78407
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2012-06-12
Regulatory Status
RX
Drug Name
FLUVASTATIN SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2012-06-12
Active Ingredient
FLUVASTATIN SODIUM
Application Number
78407
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2012-06-12
Regulatory Status
RX
Drug Name
FLUVASTATIN SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 80MG BASE
Approval Date
2016-01-27
Active Ingredient
FLUVASTATIN SODIUM
Application Number
79011
Product Number
1
Dosage Form
-
Strength
EQ 80MG BASE
Approval Date
2016-01-27
Regulatory Status
RX
Drug Name
FORMOTEROL FUMARATE
Product Number
1
Dosage Form
-
Strength
0.02MG/2ML
Approval Date
2021-06-22
Active Ingredient
FORMOTEROL FUMARATE
Application Number
91141
Product Number
1
Dosage Form
-
Strength
0.02MG/2ML
Approval Date
2021-06-22
Regulatory Status
RX
Drug Name
FOSAPREPITANT DIMEGLUMINE
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/VIAL
Approval Date
2019-09-05
Active Ingredient
FOSAPREPITANT DIMEGLUMINE
Application Number
210064
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE/VIAL
Approval Date
2019-09-05
Regulatory Status
RX
Drug Name
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
2.5MG;250MG
Approval Date
2005-10-28
Active Ingredient
GLIPIZIDE; METFORMIN HYDROCHLORIDE
Application Number
77270
Product Number
1
Dosage Form
-
Strength
2.5MG;250MG
Approval Date
2005-10-28
Regulatory Status
RX
Drug Name
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
2.5MG;500MG
Approval Date
2005-10-28
Active Ingredient
GLIPIZIDE; METFORMIN HYDROCHLORIDE
Application Number
77270
Product Number
2
Dosage Form
-
Strength
2.5MG;500MG
Approval Date
2005-10-28
Regulatory Status
RX
Drug Name
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
5MG;500MG
Approval Date
2005-10-28
Active Ingredient
GLIPIZIDE; METFORMIN HYDROCHLORIDE
Application Number
77270
Product Number
3
Dosage Form
-
Strength
5MG;500MG
Approval Date
2005-10-28
Regulatory Status
RX
Drug Name
GUANFACINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2015-06-02
Active Ingredient
GUANFACINE HYDROCHLORIDE
Application Number
201382
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2015-06-02
Regulatory Status
RX
Drug Name
GUANFACINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2015-06-02
Active Ingredient
GUANFACINE HYDROCHLORIDE
Application Number
201382
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2015-06-02
Regulatory Status
RX
Drug Name
GUANFACINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 3MG BASE
Approval Date
2015-06-02
Active Ingredient
GUANFACINE HYDROCHLORIDE
Application Number
201382
Product Number
3
Dosage Form
-
Strength
EQ 3MG BASE
Approval Date
2015-06-02
Regulatory Status
RX
Drug Name
GUANFACINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2015-06-02
Active Ingredient
GUANFACINE HYDROCHLORIDE
Application Number
201382
Product Number
4
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2015-06-02
Regulatory Status
RX
Drug Name
HYDROXYCHLOROQUINE SULFATE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1994-09-30
Active Ingredient
HYDROXYCHLOROQUINE SULFATE
Application Number
40081
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1994-09-30
Regulatory Status
RX
Drug Name
ICATIBANT ACETATE
Product Number
1
Dosage Form
-
Strength
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Approval Date
2019-07-15
Active Ingredient
ICATIBANT ACETATE
Application Number
210118
Product Number
1
Dosage Form
-
Strength
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Approval Date
2019-07-15
Regulatory Status
RX
Drug Name
ICOSAPENT ETHYL
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2020-09-11
Active Ingredient
ICOSAPENT ETHYL
Application Number
209525
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2020-09-11
Regulatory Status
RX
Drug Name
ICOSAPENT ETHYL
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2020-09-11
Active Ingredient
ICOSAPENT ETHYL
Application Number
209525
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2020-09-11
Regulatory Status
RX
Drug Name
IMATINIB MESYLATE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2016-08-04
Active Ingredient
IMATINIB MESYLATE
Application Number
204285
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2016-08-04
Regulatory Status
RX
Drug Name
IMATINIB MESYLATE
Product Number
2
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2016-08-04
Active Ingredient
IMATINIB MESYLATE
Application Number
204285
Product Number
2
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2016-08-04
Regulatory Status
RX
Drug Name
IRBESARTAN
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
2012-03-30
Active Ingredient
IRBESARTAN
Application Number
77159
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
2012-03-30
Regulatory Status
RX
Drug Name
IRBESARTAN
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
2012-03-30
Active Ingredient
IRBESARTAN
Application Number
77159
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
2012-03-30
Regulatory Status
RX
Drug Name
IRBESARTAN
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
2012-03-30
Active Ingredient
IRBESARTAN
Application Number
77159
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
2012-03-30
Regulatory Status
RX
Drug Name
IRINOTECAN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
500MG/25ML (20MG/ML)
Approval Date
2008-11-26
Active Ingredient
IRINOTECAN HYDROCHLORIDE
Application Number
90101
Product Number
1
Dosage Form
-
Strength
500MG/25ML (20MG/ML)
Approval Date
2008-11-26
Regulatory Status
RX
Drug Name
IVERMECTIN
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2019-09-13
Active Ingredient
IVERMECTIN
Application Number
210019
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2019-09-13
Regulatory Status
RX
Drug Name
LANSOPRAZOLE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2009-11-10
Active Ingredient
LANSOPRAZOLE
Application Number
77255
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2009-11-10
Regulatory Status
RX
Drug Name
LANSOPRAZOLE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2009-11-10
Active Ingredient
LANSOPRAZOLE
Application Number
77255
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2009-11-10
Regulatory Status
RX
Drug Name
LANSOPRAZOLE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2017-09-21
Active Ingredient
LANSOPRAZOLE
Application Number
208784
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2017-09-21
Regulatory Status
RX
Drug Name
LANSOPRAZOLE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2017-09-21
Active Ingredient
LANSOPRAZOLE
Application Number
208784
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2017-09-21
Regulatory Status
RX
Drug Name
LAPATINIB DITOSYLATE
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2024-08-16
Active Ingredient
LAPATINIB DITOSYLATE
Application Number
217968
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2024-08-16
Regulatory Status
RX
Drug Name
LETROZOLE
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2011-06-03
Active Ingredient
LETROZOLE
Application Number
90289
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2011-06-03
Regulatory Status
RX
Drug Name
LEVALBUTEROL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.0103% BASE
Approval Date
2013-04-26
Active Ingredient
LEVALBUTEROL HYDROCHLORIDE
Application Number
90297
Product Number
1
Dosage Form
-
Strength
EQ 0.0103% BASE
Approval Date
2013-04-26
Regulatory Status
RX
Drug Name
LEVALBUTEROL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 0.021% BASE
Approval Date
2013-04-26
Active Ingredient
LEVALBUTEROL HYDROCHLORIDE
Application Number
90297
Product Number
2
Dosage Form
-
Strength
EQ 0.021% BASE
Approval Date
2013-04-26
Regulatory Status
RX
Drug Name
LEVALBUTEROL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 0.042% BASE
Approval Date
2013-04-26
Active Ingredient
LEVALBUTEROL HYDROCHLORIDE
Application Number
90297
Product Number
3
Dosage Form
-
Strength
EQ 0.042% BASE
Approval Date
2013-04-26
Regulatory Status
RX
Drug Name
LEVOCETIRIZINE DIHYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2011-08-22
Active Ingredient
LEVOCETIRIZINE DIHYDROCHLORIDE
Application Number
90199
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2011-08-22
Regulatory Status
RX
Drug Name
LINAGLIPTIN
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2026-05-27
Active Ingredient
LINAGLIPTIN
Application Number
208433
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2026-05-27
Regulatory Status
RX
Drug Name
LIOTHYRONINE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 0.005MG BASE
Approval Date
2018-10-26
Active Ingredient
LIOTHYRONINE SODIUM
Application Number
211510
Product Number
1
Dosage Form
-
Strength
EQ 0.005MG BASE
Approval Date
2018-10-26
Regulatory Status
RX
Drug Name
LIOTHYRONINE SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 0.025MG BASE
Approval Date
2018-10-26
Active Ingredient
LIOTHYRONINE SODIUM
Application Number
211510
Product Number
2
Dosage Form
-
Strength
EQ 0.025MG BASE
Approval Date
2018-10-26
Regulatory Status
RX
Drug Name
LIOTHYRONINE SODIUM
Product Number
3
Dosage Form
-
Strength
EQ 0.05MG BASE
Approval Date
2018-10-26
Active Ingredient
LIOTHYRONINE SODIUM
Application Number
211510
Product Number
3
Dosage Form
-
Strength
EQ 0.05MG BASE
Approval Date
2018-10-26
Regulatory Status
RX
Drug Name
LIRAGLUTIDE
Product Number
1
Dosage Form
-
Strength
18MG/3ML (6MG/ML)
Approval Date
2025-08-27
Active Ingredient
LIRAGLUTIDE
Application Number
214568
Product Number
1
Dosage Form
-
Strength
18MG/3ML (6MG/ML)
Approval Date
2025-08-27
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
215415
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
215415
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
215415
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
4
Dosage Form
-
Strength
40MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
215415
Product Number
4
Dosage Form
-
Strength
40MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
5
Dosage Form
-
Strength
50MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
215415
Product Number
5
Dosage Form
-
Strength
50MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LISDEXAMFETAMINE DIMESYLATE
Product Number
6
Dosage Form
-
Strength
60MG
Approval Date
2023-08-25
Active Ingredient
LISDEXAMFETAMINE DIMESYLATE
Application Number
215415
Product Number
6
Dosage Form
-
Strength
60MG
Approval Date
2023-08-25
Regulatory Status
RX
Drug Name
LOGILIA
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
2017-02-13
Active Ingredient
ULIPRISTAL ACETATE
Application Number
207952
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
2017-02-13
Regulatory Status
RX
Drug Name
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG;50MG
Approval Date
2010-04-06
Active Ingredient
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Application Number
77157
Product Number
1
Dosage Form
-
Strength
12.5MG;50MG
Approval Date
2010-04-06
Regulatory Status
RX
Drug Name
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
12.5MG;100MG
Approval Date
2010-04-06
Active Ingredient
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Application Number
77157
Product Number
2
Dosage Form
-
Strength
12.5MG;100MG
Approval Date
2010-04-06
Regulatory Status
RX
Drug Name
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
25MG;100MG
Approval Date
2010-04-06
Active Ingredient
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Application Number
77157
Product Number
3
Dosage Form
-
Strength
25MG;100MG
Approval Date
2010-04-06
Regulatory Status
RX
Drug Name
LOSEASONIQUE
Product Number
1
Dosage Form
-
Strength
0.02MG,0.1MG;0.01MG,N/A
Approval Date
2008-10-24
Active Ingredient
ETHINYL ESTRADIOL; LEVONORGESTREL
Application Number
22262
Product Number
1
Dosage Form
-
Strength
0.02MG,0.1MG;0.01MG,N/A
Approval Date
2008-10-24
Regulatory Status
RX
Drug Name
LUBIPROSTONE
Product Number
1
Dosage Form
-
Strength
8MCG
Approval Date
2022-01-18
Active Ingredient
LUBIPROSTONE
Application Number
209920
Product Number
1
Dosage Form
-
Strength
8MCG
Approval Date
2022-01-18
Regulatory Status
RX
Drug Name
LUBIPROSTONE
Product Number
2
Dosage Form
-
Strength
24MCG
Approval Date
2022-01-18
Active Ingredient
LUBIPROSTONE
Application Number
209920
Product Number
2
Dosage Form
-
Strength
24MCG
Approval Date
2022-01-18
Regulatory Status
RX
Drug Name
MACITENTAN
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2026-06-08
Active Ingredient
MACITENTAN
Application Number
211187
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2026-06-08
Regulatory Status
RX
Drug Name
MESALAMINE
Product Number
1
Dosage Form
-
Strength
400MG
Approval Date
2019-05-09
Active Ingredient
MESALAMINE
Application Number
207873
Product Number
1
Dosage Form
-
Strength
400MG
Approval Date
2019-05-09
Regulatory Status
RX
Drug Name
METHYLERGONOVINE MALEATE
Product Number
1
Dosage Form
-
Strength
0.2MG
Approval Date
2019-03-20
Active Ingredient
METHYLERGONOVINE MALEATE
Application Number
211455
Product Number
1
Dosage Form
-
Strength
0.2MG
Approval Date
2019-03-20
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2012-07-19
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
77707
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2012-07-19
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2012-07-19
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
77707
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2012-07-19
Regulatory Status
RX
Drug Name
METHYLPHENIDATE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2012-07-19
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Application Number
77707
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2012-07-19
Regulatory Status
RX
Drug Name
METOCLOPRAMIDE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
1991-11-27
Active Ingredient
METOCLOPRAMIDE HYDROCHLORIDE
Application Number
73135
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
1991-11-27
Regulatory Status
RX
Drug Name
METRONIDAZOLE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
1984-11-06
Active Ingredient
METRONIDAZOLE
Application Number
70027
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
1984-11-06
Regulatory Status
RX
Drug Name
MICROZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
1996-12-27
Active Ingredient
HYDROCHLOROTHIAZIDE
Application Number
20504
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
1996-12-27
Regulatory Status
RX
Drug Name
MIFEPRISTONE
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2020-08-03
Active Ingredient
MIFEPRISTONE
Application Number
211436
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2020-08-03
Regulatory Status
RX
Drug Name
MONTELUKAST SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-08-03
Active Ingredient
MONTELUKAST SODIUM
Application Number
78605
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-08-03
Regulatory Status
RX
Drug Name
MONTELUKAST SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2012-08-03
Active Ingredient
MONTELUKAST SODIUM
Application Number
78723
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2012-08-03
Regulatory Status
RX
Drug Name
MONTELUKAST SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-08-03
Active Ingredient
MONTELUKAST SODIUM
Application Number
78723
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-08-03
Regulatory Status
RX
Drug Name
MOXIFLOXACIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2014-02-18
Active Ingredient
MOXIFLOXACIN HYDROCHLORIDE
Application Number
77437
Product Number
1
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2014-02-18
Regulatory Status
RX
Drug Name
MYCOPHENOLATE MOFETIL
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2009-05-06
Active Ingredient
MYCOPHENOLATE MOFETIL
Application Number
65491
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2009-05-06
Regulatory Status
RX
Drug Name
NOR-QD
Product Number
1
Dosage Form
-
Strength
0.35MG
Approval Date
1982-01-01
Active Ingredient
NORETHINDRONE
Application Number
17060
Product Number
1
Dosage Form
-
Strength
0.35MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
OCTREOTIDE ACETATE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/VIAL
Approval Date
2023-12-05
Active Ingredient
OCTREOTIDE ACETATE
Application Number
210317
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/VIAL
Approval Date
2023-12-05
Regulatory Status
RX
Drug Name
OCTREOTIDE ACETATE
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE/VIAL
Approval Date
2023-12-05
Active Ingredient
OCTREOTIDE ACETATE
Application Number
210317
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE/VIAL
Approval Date
2023-12-05
Regulatory Status
RX
Drug Name
OCTREOTIDE ACETATE
Product Number
3
Dosage Form
-
Strength
EQ 30MG BASE/VIAL
Approval Date
2023-12-05
Active Ingredient
OCTREOTIDE ACETATE
Application Number
210317
Product Number
3
Dosage Form
-
Strength
EQ 30MG BASE/VIAL
Approval Date
2023-12-05
Regulatory Status
RX
Drug Name
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE;EQ 6MG BASE
Approval Date
2012-06-19
Active Ingredient
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Application Number
77528
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE;EQ 6MG BASE
Approval Date
2012-06-19
Regulatory Status
RX
Drug Name
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE;EQ 12MG BASE
Approval Date
2012-06-19
Active Ingredient
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Application Number
77528
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE;EQ 12MG BASE
Approval Date
2012-06-19
Regulatory Status
RX
Drug Name
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE;EQ 6MG BASE
Approval Date
2012-06-19
Active Ingredient
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Application Number
77528
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE;EQ 6MG BASE
Approval Date
2012-06-19
Regulatory Status
RX
Drug Name
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 50MG BASE;EQ 12MG BASE
Approval Date
2012-06-19
Active Ingredient
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Application Number
77528
Product Number
4
Dosage Form
-
Strength
EQ 50MG BASE;EQ 12MG BASE
Approval Date
2012-06-19
Regulatory Status
RX
Drug Name
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE;EQ 3MG BASE
Approval Date
2013-03-25
Active Ingredient
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Application Number
202074
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE;EQ 3MG BASE
Approval Date
2013-03-25
Regulatory Status
RX
Drug Name
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE;12.5MG;20MG
Approval Date
2016-11-03
Active Ingredient
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Application Number
202491
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE;12.5MG;20MG
Approval Date
2016-11-03
Regulatory Status
RX
Drug Name
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE;12.5MG;40MG
Approval Date
2016-11-03
Active Ingredient
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Application Number
202491
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE;12.5MG;40MG
Approval Date
2016-11-03
Regulatory Status
RX
Drug Name
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
EQ 5MG BASE;25MG;40MG
Approval Date
2016-11-03
Active Ingredient
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Application Number
202491
Product Number
3
Dosage Form
-
Strength
EQ 5MG BASE;25MG;40MG
Approval Date
2016-11-03
Regulatory Status
RX
Drug Name
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
Product Number
4
Dosage Form
-
Strength
EQ 10MG BASE;12.5MG;40MG
Approval Date
2016-11-03
Active Ingredient
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Application Number
202491
Product Number
4
Dosage Form
-
Strength
EQ 10MG BASE;12.5MG;40MG
Approval Date
2016-11-03
Regulatory Status
RX
Drug Name
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
Product Number
5
Dosage Form
-
Strength
EQ 10MG BASE;25MG;40MG
Approval Date
2016-11-03
Active Ingredient
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Application Number
202491
Product Number
5
Dosage Form
-
Strength
EQ 10MG BASE;25MG;40MG
Approval Date
2016-11-03
Regulatory Status
RX
Drug Name
OMEPRAZOLE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2017-06-13
Active Ingredient
OMEPRAZOLE
Application Number
204661
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2017-06-13
Regulatory Status
RX
Drug Name
ONSURA
Product Number
1
Dosage Form
-
Strength
0.035MG/24HR;0.15MG/24HR
Approval Date
2021-08-25
Active Ingredient
ETHINYL ESTRADIOL; NORELGESTROMIN
Application Number
213977
Product Number
1
Dosage Form
-
Strength
0.035MG/24HR;0.15MG/24HR
Approval Date
2021-08-25
Regulatory Status
RX
Drug Name
OSELTAMIVIR PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/ML
Approval Date
2019-02-27
Active Ingredient
OSELTAMIVIR PHOSPHATE
Application Number
211125
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/ML
Approval Date
2019-02-27
Regulatory Status
RX
Drug Name
OXYBUTYNIN CHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1988-11-14
Active Ingredient
OXYBUTYNIN CHLORIDE
Application Number
71655
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1988-11-14
Regulatory Status
RX
Drug Name
PACLITAXEL
Product Number
1
Dosage Form
-
Strength
6MG/ML
Approval Date
2002-01-25
Active Ingredient
PACLITAXEL
Application Number
75184
Product Number
1
Dosage Form
-
Strength
6MG/ML
Approval Date
2002-01-25
Regulatory Status
RX
Drug Name
PALONOSETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Approval Date
2018-03-23
Active Ingredient
PALONOSETRON HYDROCHLORIDE
Application Number
90713
Product Number
1
Dosage Form
-
Strength
EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Approval Date
2018-03-23
Regulatory Status
RX
Drug Name
PARICALCITOL
Product Number
1
Dosage Form
-
Strength
1MCG
Approval Date
2013-09-27
Active Ingredient
PARICALCITOL
Application Number
90829
Product Number
1
Dosage Form
-
Strength
1MCG
Approval Date
2013-09-27
Regulatory Status
RX
Drug Name
PARICALCITOL
Product Number
2
Dosage Form
-
Strength
2MCG
Approval Date
2013-09-27
Active Ingredient
PARICALCITOL
Application Number
90829
Product Number
2
Dosage Form
-
Strength
2MCG
Approval Date
2013-09-27
Regulatory Status
RX
Drug Name
PARICALCITOL
Product Number
3
Dosage Form
-
Strength
4MCG
Approval Date
2013-09-27
Active Ingredient
PARICALCITOL
Application Number
90829
Product Number
3
Dosage Form
-
Strength
4MCG
Approval Date
2013-09-27
Regulatory Status
RX
Drug Name
PENCICLOVIR
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2022-11-09
Active Ingredient
PENCICLOVIR
Application Number
212710
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2022-11-09
Regulatory Status
RX
Drug Name
PENICILLIN-VK
Product Number
1
Dosage Form
-
Strength
EQ 125MG BASE/5ML
Approval Date
1982-01-01
Active Ingredient
PENICILLIN V POTASSIUM
Application Number
60456
Product Number
1
Dosage Form
-
Strength
EQ 125MG BASE/5ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PENICILLIN-VK
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE/5ML
Approval Date
1982-01-01
Active Ingredient
PENICILLIN V POTASSIUM
Application Number
60456
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE/5ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PENICILLIN-VK
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
1982-01-01
Active Ingredient
PENICILLIN V POTASSIUM
Application Number
60711
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PENICILLIN-VK
Product Number
3
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
1982-01-01
Active Ingredient
PENICILLIN V POTASSIUM
Application Number
60711
Product Number
3
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2025-05-23
Active Ingredient
PERAMPANEL
Application Number
209801
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2025-05-23
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
2025-05-23
Active Ingredient
PERAMPANEL
Application Number
209801
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
2025-05-23
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
3
Dosage Form
-
Strength
6MG
Approval Date
2025-05-23
Active Ingredient
PERAMPANEL
Application Number
209801
Product Number
3
Dosage Form
-
Strength
6MG
Approval Date
2025-05-23
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
4
Dosage Form
-
Strength
8MG
Approval Date
2025-05-23
Active Ingredient
PERAMPANEL
Application Number
209801
Product Number
4
Dosage Form
-
Strength
8MG
Approval Date
2025-05-23
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
5
Dosage Form
-
Strength
10MG
Approval Date
2025-05-23
Active Ingredient
PERAMPANEL
Application Number
209801
Product Number
5
Dosage Form
-
Strength
10MG
Approval Date
2025-05-23
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
6
Dosage Form
-
Strength
12MG
Approval Date
2025-05-23
Active Ingredient
PERAMPANEL
Application Number
209801
Product Number
6
Dosage Form
-
Strength
12MG
Approval Date
2025-05-23
Regulatory Status
RX
Drug Name
PIOGLITAZONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 15MG BASE
Approval Date
2014-01-10
Active Ingredient
PIOGLITAZONE HYDROCHLORIDE
Application Number
77210
Product Number
1
Dosage Form
-
Strength
EQ 15MG BASE
Approval Date
2014-01-10
Regulatory Status
RX
Drug Name
PIOGLITAZONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 30MG BASE
Approval Date
2014-01-10
Active Ingredient
PIOGLITAZONE HYDROCHLORIDE
Application Number
77210
Product Number
2
Dosage Form
-
Strength
EQ 30MG BASE
Approval Date
2014-01-10
Regulatory Status
RX
Drug Name
PIOGLITAZONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 45MG BASE
Approval Date
2014-01-10
Active Ingredient
PIOGLITAZONE HYDROCHLORIDE
Application Number
77210
Product Number
3
Dosage Form
-
Strength
EQ 45MG BASE
Approval Date
2014-01-10
Regulatory Status
RX
Drug Name
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
500MG;EQ 15MG BASE
Approval Date
2014-03-10
Active Ingredient
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Application Number
91155
Product Number
1
Dosage Form
-
Strength
500MG;EQ 15MG BASE
Approval Date
2014-03-10
Regulatory Status
RX
Drug Name
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
850MG;EQ 15MG BASE
Approval Date
2014-03-10
Active Ingredient
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Application Number
91155
Product Number
2
Dosage Form
-
Strength
850MG;EQ 15MG BASE
Approval Date
2014-03-10
Regulatory Status
RX
Drug Name
PIRFENIDONE
Product Number
1
Dosage Form
-
Strength
267MG
Approval Date
2022-01-25
Active Ingredient
PIRFENIDONE
Application Number
212759
Product Number
1
Dosage Form
-
Strength
267MG
Approval Date
2022-01-25
Regulatory Status
RX
Drug Name
PIRFENIDONE
Product Number
2
Dosage Form
-
Strength
801MG
Approval Date
2022-01-25
Active Ingredient
PIRFENIDONE
Application Number
212759
Product Number
2
Dosage Form
-
Strength
801MG
Approval Date
2022-01-25
Regulatory Status
RX
Drug Name
POMALIDOMIDE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2022-05-04
Active Ingredient
POMALIDOMIDE
Application Number
209956
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2022-05-04
Regulatory Status
RX
Drug Name
POMALIDOMIDE
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2022-05-04
Active Ingredient
POMALIDOMIDE
Application Number
209956
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2022-05-04
Regulatory Status
RX
Drug Name
POMALIDOMIDE
Product Number
3
Dosage Form
-
Strength
3MG
Approval Date
2022-05-04
Active Ingredient
POMALIDOMIDE
Application Number
209956
Product Number
3
Dosage Form
-
Strength
3MG
Approval Date
2022-05-04
Regulatory Status
RX
Drug Name
POMALIDOMIDE
Product Number
4
Dosage Form
-
Strength
4MG
Approval Date
2022-05-04
Active Ingredient
POMALIDOMIDE
Application Number
209956
Product Number
4
Dosage Form
-
Strength
4MG
Approval Date
2022-05-04
Regulatory Status
RX
Drug Name
POTASSIUM CITRATE
Product Number
1
Dosage Form
-
Strength
5MEQ
Approval Date
2018-03-05
Active Ingredient
POTASSIUM CITRATE
Application Number
209758
Product Number
1
Dosage Form
-
Strength
5MEQ
Approval Date
2018-03-05
Regulatory Status
RX
Drug Name
POTASSIUM CITRATE
Product Number
2
Dosage Form
-
Strength
10MEQ
Approval Date
2018-03-05
Active Ingredient
POTASSIUM CITRATE
Application Number
209758
Product Number
2
Dosage Form
-
Strength
10MEQ
Approval Date
2018-03-05
Regulatory Status
RX
Drug Name
POTASSIUM CITRATE
Product Number
3
Dosage Form
-
Strength
15MEQ
Approval Date
2018-03-05
Active Ingredient
POTASSIUM CITRATE
Application Number
209758
Product Number
3
Dosage Form
-
Strength
15MEQ
Approval Date
2018-03-05
Regulatory Status
RX
Drug Name
PRAZOSIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
1988-09-12
Active Ingredient
PRAZOSIN HYDROCHLORIDE
Application Number
71745
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
1988-09-12
Regulatory Status
RX
Drug Name
PRAZOSIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
1988-09-12
Active Ingredient
PRAZOSIN HYDROCHLORIDE
Application Number
71745
Product Number
2
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
1988-09-12
Regulatory Status
RX
Drug Name
PRAZOSIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
1988-09-12
Active Ingredient
PRAZOSIN HYDROCHLORIDE
Application Number
71745
Product Number
3
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
1988-09-12
Regulatory Status
RX
Drug Name
PROAIR HFA
Product Number
1
Dosage Form
-
Strength
EQ 0.09MG BASE/INH
Approval Date
2004-10-29
Active Ingredient
ALBUTEROL SULFATE
Application Number
21457
Product Number
1
Dosage Form
-
Strength
EQ 0.09MG BASE/INH
Approval Date
2004-10-29
Regulatory Status
RX
Drug Name
PROAIR RESPICLICK
Product Number
1
Dosage Form
-
Strength
EQ 0.09MG BASE/INH
Approval Date
2015-03-31
Active Ingredient
ALBUTEROL SULFATE
Application Number
205636
Product Number
1
Dosage Form
-
Strength
EQ 0.09MG BASE/INH
Approval Date
2015-03-31
Regulatory Status
RX
Drug Name
PROGLYCEM
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Active Ingredient
DIAZOXIDE
Application Number
17453
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
PYRIMETHAMINE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2021-08-13
Active Ingredient
PYRIMETHAMINE
Application Number
215506
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2021-08-13
Regulatory Status
RX
Drug Name
QNASL
Product Number
1
Dosage Form
-
Strength
0.08MG/ACTUATION
Approval Date
2012-03-23
Active Ingredient
BECLOMETHASONE DIPROPIONATE
Application Number
202813
Product Number
1
Dosage Form
-
Strength
0.08MG/ACTUATION
Approval Date
2012-03-23
Regulatory Status
RX
Drug Name
QNASL
Product Number
2
Dosage Form
-
Strength
0.04MG/ACTUATION
Approval Date
2014-12-17
Active Ingredient
BECLOMETHASONE DIPROPIONATE
Application Number
202813
Product Number
2
Dosage Form
-
Strength
0.04MG/ACTUATION
Approval Date
2014-12-17
Regulatory Status
RX
Drug Name
QUARTETTE
Product Number
1
Dosage Form
-
Strength
0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A
Approval Date
2013-03-28
Active Ingredient
ETHINYL ESTRADIOL; LEVONORGESTREL
Application Number
204061
Product Number
1
Dosage Form
-
Strength
0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A
Approval Date
2013-03-28
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
77745
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
77745
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
77745
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
4
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
77745
Product Number
4
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
5
Dosage Form
-
Strength
EQ 200MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
77745
Product Number
5
Dosage Form
-
Strength
EQ 200MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
6
Dosage Form
-
Strength
EQ 300MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
77745
Product Number
6
Dosage Form
-
Strength
EQ 300MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUETIAPINE FUMARATE
Product Number
7
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2012-03-27
Active Ingredient
QUETIAPINE FUMARATE
Application Number
77745
Product Number
7
Dosage Form
-
Strength
EQ 400MG BASE
Approval Date
2012-03-27
Regulatory Status
RX
Drug Name
QUININE SULFATE
Product Number
1
Dosage Form
-
Strength
324MG
Approval Date
2012-09-28
Active Ingredient
QUININE SULFATE
Application Number
91661
Product Number
1
Dosage Form
-
Strength
324MG
Approval Date
2012-09-28
Regulatory Status
RX
Drug Name
RALOXIFENE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2014-03-04
Active Ingredient
RALOXIFENE HYDROCHLORIDE
Application Number
78193
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2014-03-04
Regulatory Status
RX
Drug Name
RISEDRONATE SODIUM
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2007-10-05
Active Ingredient
RISEDRONATE SODIUM
Application Number
77132
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2007-10-05
Regulatory Status
RX
Drug Name
RISEDRONATE SODIUM
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2007-10-05
Active Ingredient
RISEDRONATE SODIUM
Application Number
77132
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2007-10-05
Regulatory Status
RX
Drug Name
RISEDRONATE SODIUM
Product Number
3
Dosage Form
-
Strength
35MG
Approval Date
2007-10-05
Active Ingredient
RISEDRONATE SODIUM
Application Number
77132
Product Number
3
Dosage Form
-
Strength
35MG
Approval Date
2007-10-05
Regulatory Status
RX
Drug Name
RISEDRONATE SODIUM
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2014-06-13
Active Ingredient
RISEDRONATE SODIUM
Application Number
79215
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2014-06-13
Regulatory Status
RX
Drug Name
RISEDRONATE SODIUM
Product Number
1
Dosage Form
-
Strength
35MG
Approval Date
2015-05-18
Active Ingredient
RISEDRONATE SODIUM
Application Number
203217
Product Number
1
Dosage Form
-
Strength
35MG
Approval Date
2015-05-18
Regulatory Status
RX
Drug Name
RISPERIDONE
Product Number
1
Dosage Form
-
Strength
12.5MG/VIAL
Approval Date
2023-12-05
Active Ingredient
RISPERIDONE
Application Number
214068
Product Number
1
Dosage Form
-
Strength
12.5MG/VIAL
Approval Date
2023-12-05
Regulatory Status
RX
Drug Name
RISPERIDONE
Product Number
2
Dosage Form
-
Strength
25MG/VIAL
Approval Date
2023-12-05
Active Ingredient
RISPERIDONE
Application Number
214068
Product Number
2
Dosage Form
-
Strength
25MG/VIAL
Approval Date
2023-12-05
Regulatory Status
RX
Drug Name
RISPERIDONE
Product Number
3
Dosage Form
-
Strength
37.5MG/VIAL
Approval Date
2023-12-05
Active Ingredient
RISPERIDONE
Application Number
214068
Product Number
3
Dosage Form
-
Strength
37.5MG/VIAL
Approval Date
2023-12-05
Regulatory Status
RX
Drug Name
RISPERIDONE
Product Number
4
Dosage Form
-
Strength
50MG/VIAL
Approval Date
2023-12-05
Active Ingredient
RISPERIDONE
Application Number
214068
Product Number
4
Dosage Form
-
Strength
50MG/VIAL
Approval Date
2023-12-05
Regulatory Status
RX
Drug Name
RIZATRIPTAN BENZOATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-12-31
Active Ingredient
RIZATRIPTAN BENZOATE
Application Number
77263
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-12-31
Regulatory Status
RX
Drug Name
RIZATRIPTAN BENZOATE
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-12-31
Active Ingredient
RIZATRIPTAN BENZOATE
Application Number
77263
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-12-31
Regulatory Status
RX
Drug Name
SEASONALE
Product Number
1
Dosage Form
-
Strength
0.03MG;0.15MG
Approval Date
2003-09-05
Active Ingredient
ETHINYL ESTRADIOL; LEVONORGESTREL
Application Number
21544
Product Number
1
Dosage Form
-
Strength
0.03MG;0.15MG
Approval Date
2003-09-05
Regulatory Status
RX
Drug Name
SEASONIQUE
Product Number
1
Dosage Form
-
Strength
0.03MG,0.01MG;0.15MG,N/A
Approval Date
2006-05-25
Active Ingredient
ETHINYL ESTRADIOL; LEVONORGESTREL
Application Number
21840
Product Number
1
Dosage Form
-
Strength
0.03MG,0.01MG;0.15MG,N/A
Approval Date
2006-05-25
Regulatory Status
RX
Drug Name
SILDENAFIL CITRATE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
2020-05-29
Active Ingredient
SILDENAFIL CITRATE
Application Number
211534
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE/ML
Approval Date
2020-05-29
Regulatory Status
RX
Drug Name
SOLIFENACIN SUCCINATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2014-04-02
Active Ingredient
SOLIFENACIN SUCCINATE
Application Number
91464
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2014-04-02
Regulatory Status
RX
Drug Name
SOLIFENACIN SUCCINATE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2014-04-02
Active Ingredient
SOLIFENACIN SUCCINATE
Application Number
91464
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2014-04-02
Regulatory Status
RX
Drug Name
SORAFENIB TOSYLATE
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE
Approval Date
2020-11-12
Active Ingredient
SORAFENIB TOSYLATE
Application Number
209567
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE
Approval Date
2020-11-12
Regulatory Status
RX
Drug Name
SUGAMMADEX SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Approval Date
2026-07-28
Active Ingredient
SUGAMMADEX SODIUM
Application Number
214126
Product Number
1
Dosage Form
-
Strength
EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Approval Date
2026-07-28
Regulatory Status
RX
Drug Name
SUGAMMADEX SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/5ML (EQ 100MG BASE/ML)
Approval Date
2026-07-28
Active Ingredient
SUGAMMADEX SODIUM
Application Number
214126
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/5ML (EQ 100MG BASE/ML)
Approval Date
2026-07-28
Regulatory Status
RX
Drug Name
SULFAMETHOXAZOLE AND TRIMETHOPRIM
Product Number
1
Dosage Form
-
Strength
80MG/ML;16MG/ML
Approval Date
1991-10-31
Active Ingredient
SULFAMETHOXAZOLE; TRIMETHOPRIM
Application Number
73303
Product Number
1
Dosage Form
-
Strength
80MG/ML;16MG/ML
Approval Date
1991-10-31
Regulatory Status
RX
Drug Name
SUNITINIB MALATE
Product Number
1
Dosage Form
-
Strength
EQ 12.5MG BASE
Approval Date
2021-11-30
Active Ingredient
SUNITINIB MALATE
Application Number
213803
Product Number
1
Dosage Form
-
Strength
EQ 12.5MG BASE
Approval Date
2021-11-30
Regulatory Status
RX
Drug Name
SUNITINIB MALATE
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2021-11-30
Active Ingredient
SUNITINIB MALATE
Application Number
213803
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2021-11-30
Regulatory Status
RX
Drug Name
SUNITINIB MALATE
Product Number
3
Dosage Form
-
Strength
EQ 37.5MG BASE
Approval Date
2021-11-30
Active Ingredient
SUNITINIB MALATE
Application Number
213803
Product Number
3
Dosage Form
-
Strength
EQ 37.5MG BASE
Approval Date
2021-11-30
Regulatory Status
RX
Drug Name
SUNITINIB MALATE
Product Number
4
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2021-11-30
Active Ingredient
SUNITINIB MALATE
Application Number
213803
Product Number
4
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2021-11-30
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2018-05-22
Active Ingredient
TADALAFIL
Application Number
90141
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2018-05-22
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2018-05-22
Active Ingredient
TADALAFIL
Application Number
90141
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2018-05-22
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2018-05-22
Active Ingredient
TADALAFIL
Application Number
90141
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2018-05-22
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2018-05-22
Active Ingredient
TADALAFIL
Application Number
90141
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2018-05-22
Regulatory Status
RX
Drug Name
TAMSULOSIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.4MG
Approval Date
2010-04-27
Active Ingredient
TAMSULOSIN HYDROCHLORIDE
Application Number
77630
Product Number
1
Dosage Form
-
Strength
0.4MG
Approval Date
2010-04-27
Regulatory Status
RX
Drug Name
TASIMELTEON
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2022-12-12
Active Ingredient
TASIMELTEON
Application Number
211601
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2022-12-12
Regulatory Status
RX
Drug Name
TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2015-03-18
Active Ingredient
TENOFOVIR DISOPROXIL FUMARATE
Application Number
91612
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2015-03-18
Regulatory Status
RX
Drug Name
TENOFOVIR DISOPROXIL FUMARATE
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
2018-01-26
Active Ingredient
TENOFOVIR DISOPROXIL FUMARATE
Application Number
91612
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
2018-01-26
Regulatory Status
RX
Drug Name
TENOFOVIR DISOPROXIL FUMARATE
Product Number
3
Dosage Form
-
Strength
200MG
Approval Date
2018-01-26
Active Ingredient
TENOFOVIR DISOPROXIL FUMARATE
Application Number
91612
Product Number
3
Dosage Form
-
Strength
200MG
Approval Date
2018-01-26
Regulatory Status
RX
Drug Name
TENOFOVIR DISOPROXIL FUMARATE
Product Number
4
Dosage Form
-
Strength
250MG
Approval Date
2018-01-26
Active Ingredient
TENOFOVIR DISOPROXIL FUMARATE
Application Number
91612
Product Number
4
Dosage Form
-
Strength
250MG
Approval Date
2018-01-26
Regulatory Status
RX
Drug Name
TERIFLUNOMIDE
Product Number
1
Dosage Form
-
Strength
7MG
Approval Date
2018-09-04
Active Ingredient
TERIFLUNOMIDE
Application Number
209700
Product Number
1
Dosage Form
-
Strength
7MG
Approval Date
2018-09-04
Regulatory Status
RX
Drug Name
TERIFLUNOMIDE
Product Number
2
Dosage Form
-
Strength
14MG
Approval Date
2018-09-04
Active Ingredient
TERIFLUNOMIDE
Application Number
209700
Product Number
2
Dosage Form
-
Strength
14MG
Approval Date
2018-09-04
Regulatory Status
RX
Drug Name
TERIPARATIDE
Product Number
1
Dosage Form
-
Strength
0.56MG/2.24ML (0.25MG/ML)
Approval Date
2023-11-16
Active Ingredient
TERIPARATIDE
Application Number
208569
Product Number
1
Dosage Form
-
Strength
0.56MG/2.24ML (0.25MG/ML)
Approval Date
2023-11-16
Regulatory Status
RX
Drug Name
TIOPRONIN
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2021-04-26
Active Ingredient
TIOPRONIN
Application Number
214326
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2021-04-26
Regulatory Status
RX
Drug Name
TOBRAMYCIN
Product Number
1
Dosage Form
-
Strength
300MG/5ML
Approval Date
2013-10-10
Active Ingredient
TOBRAMYCIN
Application Number
91589
Product Number
1
Dosage Form
-
Strength
300MG/5ML
Approval Date
2013-10-10
Regulatory Status
RX
Drug Name
TOLTERODINE TARTRATE
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2016-11-22
Active Ingredient
TOLTERODINE TARTRATE
Application Number
79141
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2016-11-22
Regulatory Status
RX
Drug Name
TOLTERODINE TARTRATE
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
2016-11-22
Active Ingredient
TOLTERODINE TARTRATE
Application Number
79141
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
2016-11-22
Regulatory Status
RX
Drug Name
TRAZODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1987-12-11
Active Ingredient
TRAZODONE HYDROCHLORIDE
Application Number
71523
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1987-12-11
Regulatory Status
RX
Drug Name
TRAZODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1987-12-11
Active Ingredient
TRAZODONE HYDROCHLORIDE
Application Number
71524
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1987-12-11
Regulatory Status
RX
Drug Name
TREPROSTINIL
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2019-09-26
Active Ingredient
TREPROSTINIL
Application Number
206648
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2019-09-26
Regulatory Status
RX
Drug Name
TREPROSTINIL
Product Number
2
Dosage Form
-
Strength
2.5MG/ML
Approval Date
2019-09-26
Active Ingredient
TREPROSTINIL
Application Number
206648
Product Number
2
Dosage Form
-
Strength
2.5MG/ML
Approval Date
2019-09-26
Regulatory Status
RX
Drug Name
TREPROSTINIL
Product Number
3
Dosage Form
-
Strength
5MG/ML
Approval Date
2019-09-26
Active Ingredient
TREPROSTINIL
Application Number
206648
Product Number
3
Dosage Form
-
Strength
5MG/ML
Approval Date
2019-09-26
Regulatory Status
RX
Drug Name
TREPROSTINIL
Product Number
4
Dosage Form
-
Strength
10MG/ML
Approval Date
2019-09-26
Active Ingredient
TREPROSTINIL
Application Number
206648
Product Number
4
Dosage Form
-
Strength
10MG/ML
Approval Date
2019-09-26
Regulatory Status
RX
Drug Name
TRIAMCINOLONE ACETONIDE
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2018-10-05
Active Ingredient
TRIAMCINOLONE ACETONIDE
Application Number
209852
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2018-10-05
Regulatory Status
RX
Drug Name
VANDAZOLE
Product Number
1
Dosage Form
-
Strength
0.75%
Approval Date
2005-05-20
Active Ingredient
METRONIDAZOLE
Application Number
21806
Product Number
1
Dosage Form
-
Strength
0.75%
Approval Date
2005-05-20
Regulatory Status
RX
Drug Name
VARDENAFIL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2012-05-03
Active Ingredient
VARDENAFIL HYDROCHLORIDE
Application Number
91347
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2012-05-03
Regulatory Status
RX
Drug Name
VARDENAFIL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-05-03
Active Ingredient
VARDENAFIL HYDROCHLORIDE
Application Number
91347
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-05-03
Regulatory Status
RX
Drug Name
VARDENAFIL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-05-03
Active Ingredient
VARDENAFIL HYDROCHLORIDE
Application Number
91347
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-05-03
Regulatory Status
RX
Drug Name
VARDENAFIL HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2012-05-03
Active Ingredient
VARDENAFIL HYDROCHLORIDE
Application Number
91347
Product Number
4
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2012-05-03
Regulatory Status
RX
Drug Name
VIGABATRIN
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2019-01-14
Active Ingredient
VIGABATRIN
Application Number
209822
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2019-01-14
Regulatory Status
RX
Drug Name
VILAZODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2019-09-30
Active Ingredient
VILAZODONE HYDROCHLORIDE
Application Number
208212
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2019-09-30
Regulatory Status
RX
Drug Name
VILAZODONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2019-09-30
Active Ingredient
VILAZODONE HYDROCHLORIDE
Application Number
208212
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2019-09-30
Regulatory Status
RX
Drug Name
VILAZODONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2019-09-30
Active Ingredient
VILAZODONE HYDROCHLORIDE
Application Number
208212
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2019-09-30
Regulatory Status
RX
Drug Name
ZIAC
Product Number
1
Dosage Form
-
Strength
5MG;6.25MG
Approval Date
1993-03-26
Active Ingredient
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Application Number
20186
Product Number
1
Dosage Form
-
Strength
5MG;6.25MG
Approval Date
1993-03-26
Regulatory Status
RX
Drug Name
ZIAC
Product Number
2
Dosage Form
-
Strength
10MG;6.25MG
Approval Date
1993-03-26
Active Ingredient
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Application Number
20186
Product Number
2
Dosage Form
-
Strength
10MG;6.25MG
Approval Date
1993-03-26
Regulatory Status
RX
Drug Name
ZIAC
Product Number
3
Dosage Form
-
Strength
2.5MG;6.25MG
Approval Date
1993-03-26
Active Ingredient
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Application Number
20186
Product Number
3
Dosage Form
-
Strength
2.5MG;6.25MG
Approval Date
1993-03-26
Regulatory Status
RX
Drug Status Breakdown
338 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ACITRETIN
Application Number
202897
Product Number
1
Active Ingredient
ACITRETIN
Dosage Form
-
Strength
17.5MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.